Cartesian Aurora What is the AURORA Study? The aim of the AURORA Study is to assess the safety and effectiveness of an mRNA CAR T-cell therapy, known as Descartes-08, as a potential approach to treat generalized myasthenia gravis. Myasthenia gravis is an autoimmune disease, which means that the immune system mistakenly produces antibodies (proteins that […]
Novartis “Relieve” We are assessing the effectiveness and safety of remibrutinib, an investigational medicine being developed for people who have generalized Myasthenia Gravis (gMG). Click here for More Information Inclusion Criteria: – Have a confirmed, documented diagnosis of gMG: either positive for AChR+ antibody or MuSK+ antibody, or seronegative for both AChR and MuSK antibodies
Novartis “Relieve” Read More »
